翻译这段话:Klapproth等人比较德国乳腺癌患者样本中QLU-C10D和PROPr两种分数虽然两种量表具有很强的相关性但由于两种量表间对HSU的测量方式不同因此不能判断哪一个量表在乳腺癌患者中有更好的得分。除此之外大多数研究使用EQ-5D作为标尺验证了QLU-C10D的测量属性。例如两篇研究比较了EQ-5D-3L和C10D实用程序的测量特性和对QALY计算的影响。Gamper等人在骨髓增生异常
Klapproth and colleagues compared QLU-C10D and PROPr scores in samples of German breast cancer patients. Although the two scales showed a strong correlation, it cannot be determined which scale had a better score in breast cancer patients because of the different measurement methods for HSU between the two scales. In addition, most studies used EQ-5D as a reference scale and validated the measurement properties of QLU-C10D. For example, two studies compared the measurement properties and impact on QALY calculation between EQ-5D-3L and C10D utility measures. Gamper and colleagues compared the relative validity of QLU-C10D and EQ-5D-3L in myelodysplastic syndrome and found that the QLU-C1OD scale had better validity and was more suitable for economic evaluation studies of MDS. However, Bulamu and colleagues compared the responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in post-esophageal cancer surgery patients and found that the measurement properties of QLU-C1OD and EQ-5D-3L scales were comparable. From existing research results, there are some differences in the conclusions obtained from comparing 5L and 3L with QLU-C10D. For example, Chen-Wei Pan and colleagues first chose EQ-5D-5L as a universal scale and compared the measurement properties of utility scores from different country-specific value sets with QLU-C10D, demonstrating that the two scales had similar convergent validity and between-group validity, and EQ-5D-5L scores may have better discriminative ability. This study validated the relevant measurement properties of QLU-C10D in Chinese cancer patients, but did not use it because at that time a utility scoring system based on the Chinese population had not been established
原文地址: http://www.cveoy.top/t/topic/h7Q2 著作权归作者所有。请勿转载和采集!